GABRG2 rs3740066: Understanding Genetic Associations
The rs3740066 variant is a genetic marker located within the GABRG2 gene, which encodes a critical subunit of the GABA-A receptor. Research has investigated this variant for its potential associations with variations in receptor expression and susceptibility to epilepsy-related conditions.
What each genotype means
Increased risk profile
This genotype is associated with a higher statistical risk for intrahepatic cholestasis of pregnancy compared to the common genotype. Please note that this association is based on specific population studies and does not guarantee the development of any condition. Discuss any health concerns or pregnancy management with your obstetrician.
This genotype is less common than the G allele across most studied populations.
Slightly increased risk profile
Individuals with this genotype may have a slightly elevated statistical risk for intrahepatic cholestasis of pregnancy compared to those with the GG genotype. This finding is based on observational research and should be interpreted as a general trend rather than a diagnostic indicator. Consult your healthcare provider for personalized medical guidance.
This heterozygous genotype is found at moderate frequencies in many global populations.
Average risk profile
This is considered the common or typical genotype for this variant in the general population. There is no evidence suggesting this specific genotype confers an increased risk for the conditions associated with this variant. No specific medical action is indicated based on this result alone.
This is the most common genotype observed across most major ancestral groups.
What is rs3740066 and Where is it Located?
The variant rs3740066 is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The GABRG2 gene is located on chromosome 5 and provides the instructions for creating the gamma-2 subunit of the GABA-A receptor. This receptor is a ligand-gated ion channel that plays a fundamental role in the central nervous system. By acting as a site for the neurotransmitter GABA, these receptors facilitate inhibitory signaling, which helps balance neuronal activity. Because rs3740066 is located within this gene, researchers study it to determine if it influences how these receptors are built, expressed, or regulated in the brain, potentially impacting the overall stability of neural circuits.
The Role of the GABRG2 Gene
The GABRG2 gene is essential for normal brain function because it encodes the gamma-2 subunit of the GABA-A receptor. These receptors are the primary mediators of fast inhibitory neurotransmission in the mammalian brain. When GABA binds to these receptors, they open to allow chloride ions to flow into neurons, which reduces the likelihood of the neuron firing an electrical signal. This inhibitory process is vital for preventing over-excitation in the brain. Mutations or variations that alter the function of the GABRG2 gene can disrupt this delicate balance. Scientific literature has linked various pathogenic mutations in GABRG2 to a spectrum of epilepsy syndromes, ranging from simple febrile seizures to more severe conditions like Dravet syndrome. Understanding how variants like rs3740066 might influence this gene's expression is a key area of ongoing neurological research.
Research Associations and Evidence Strength
The evidence linking rs3740066 to clinical outcomes is considered moderate and is primarily based on statistical associations observed in population studies. While specific rare mutations in GABRG2 are well-documented as causes of severe epilepsy, the role of common variants like rs3740066 is more nuanced. Research has explored whether this variant correlates with differences in GABA-A receptor subunit expression, which could theoretically influence an individual's seizure threshold. However, it is important to distinguish between rare, highly penetrant mutations that directly cause disease and common SNPs that may only slightly modify risk. Current findings suggest that while GABRG2 is a significant gene in epilepsy research, the specific contribution of rs3740066 to clinical epilepsy remains a subject of investigation. It is not a diagnostic marker, and its presence does not guarantee the development of any specific health condition.
Population Frequency
The rs3740066 variant is classified as a common SNP, meaning it is found at a relatively high frequency across diverse human populations. Genetic databases indicate that the variant alleles are widely distributed, though the exact proportions of each genotype can vary depending on ancestral background. Because it is common, most individuals carry at least one copy of the variant, which is consistent with the nature of many non-pathogenic or low-impact genetic markers. Large-scale genomic studies, such as those found in gnomAD, provide the data necessary to track these frequencies across global cohorts. Understanding these frequencies helps researchers determine if a variant is likely to be a rare driver of disease or a common feature of human genetic diversity.
What You Can and Cannot Do With This Information
Genetic information regarding variants like rs3740066 is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. If you have concerns about epilepsy, seizure history, or neurological health, it is essential to consult with a qualified healthcare professional or a neurologist. They can provide a clinical evaluation that considers your full medical history, family history, and symptoms, which are far more predictive of health outcomes than a single genetic variant. You cannot use this information to predict your future health or to alter any prescribed medications. If you are currently taking medication for a neurological condition, never change your dosage or treatment plan without speaking to your clinician or pharmacist. Genetic research is a rapidly evolving field, and findings are often updated as new data becomes available.
How common is this variant?
The rs3740066 variant is a common SNP found across diverse global populations, with its specific genotypes appearing frequently in the general public.
Frequently asked questions
Is rs3740066 a cause of epilepsy?
No, rs3740066 is a common genetic variant and is not considered a direct cause of epilepsy. While the GABRG2 gene is associated with epilepsy, most cases are linked to rare, specific mutations rather than common SNPs.
Should I be worried if I have this variant?
No, there is no reason for concern. This variant is common in the general population and is not a diagnostic marker for any disease.
Can I use this to predict my risk of seizures?
No, this variant cannot be used to predict your risk of seizures. Epilepsy is a complex condition influenced by many genetic and environmental factors that cannot be determined by a single SNP.
Where can I learn more about GABRG2?
You can find reliable information about the GABRG2 gene through resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene functions and their roles in human health.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3740066?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.